Nuclear receptor corepressor 1 is a potential diagnostic and prognostic biomarker in clear cell renal cell carcinoma

Key Points

• Nuclear receptor corepressor 1 shows promise as a prognostic biomarker for patient outcomes.
• The study highlights its potential utility in both diagnostic and predictive capabilities for clear cell renal cell carcinoma.
• Assessment using tumor samples reveals significant correlations between corepressor levels and clinical prognosis.
• These findings indicate new avenues for targeted therapies and patient management strategies.